Research and experimental development on natural sciences and engineering
PHARMA HOLDINGS AS
Revenue 2024
NOK 120,000
Operating profit
NOK −17.8m
Equity
NOK 8.2m
Incorporated
2016
Employees
5
Share capital
NOK 1.4m
Roles
Daglig lederChristian Georg Lütken
Regnskapsfører
Revisor
Styrets lederBernt Endrerud
StyremedlemHåvard Selby Ebbestad
StyremedlemCecilia Ann-Christin Malmborg Hager
StyremedlemSidey Agneta Christina Svedberg
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| CARE HOLDING AS | 40.3% | 546097.000000 | 2025 |
| TAJ HOLDING AS | 11.3% | 152794.000000 | 2025 |
| SATURN INVEST AS | 7.1% | 95928.000000 | 2025 |
| CONSEPT EIENDOM AS | 6.0% | 81500.000000 | 2025 |
| AGIR AS | 5.5% | 74622.000000 | 2025 |
| BRØDRENE KARLSEN HOLDING AS | 5.2% | 70731.000000 | 2025 |
| JAKOB HATTELAND HOLDING AS | 4.8% | 65359.000000 | 2025 |
| ODD BERG AS | 2.7% | 37107.000000 | 2025 |
| CHRISTIAN GEORG LÜTKEN | 1.5% | 20000.000000 | 2025 |
| LUKAS I AS | 1.0% | 13641.000000 | 2025 |
| HARILA EIENDOM AS | 1.0% | 13000.000000 | 2025 |
| 3T PRODUKTER HOLDING AS | 1.0% | 12965.000000 | 2025 |
| TUT AS | 0.9% | 12500.000000 | 2025 |
| LARS HARRY VORLAND | 0.9% | 12500.000000 | 2025 |
| DORIS KATE SØRENSEN | 0.9% | 12159.000000 | 2025 |
| TAVE INVEST AS | 0.9% | 12107.000000 | 2025 |
| STOKO AS | 0.7% | 10015.000000 | 2025 |
| HOPEN INVEST AS | 0.7% | 10010.000000 | 2025 |
| SEED CAPITAL AS | 0.7% | 10000.000000 | 2025 |
| LYSNES INVEST AS | 0.7% | 8807.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| PEPTIDE PATENTS AS | Active | 50.0% | 5.000000 |
| PHARMASUM THERAPEUTICS AS | Active | 2.1% | 68142.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.